| Year |
Citation |
Score |
| 2012 |
Ayala R, Kett LR, Leach TL, Young AB, Dunah AW, Orlando LR. Metabotropic glutamate receptor 1 (mGluR1): antibody specificity and receptor expression in cultured primary neurons. Journal of Neuroscience Methods. 204: 221-6. PMID 22155385 DOI: 10.1016/j.jneumeth.2011.11.014 |
0.503 |
|
| 2010 |
Zucker B, Kama JA, Kuhn A, Thu D, Orlando LR, Dunah AW, Gokce O, Taylor DM, Lambeck J, Friedrich B, Lindenberg KS, Faull RL, Weiller C, Young AB, Luthi-Carter R. Decreased Lin7b expression in layer 5 pyramidal neurons may contribute to impaired corticostriatal connectivity in huntington disease. Journal of Neuropathology and Experimental Neurology. 69: 880-95. PMID 20720508 DOI: 10.1097/Nen.0B013E3181Ed7A41 |
0.438 |
|
| 2010 |
Lindenberg KS, Davranche A, Klein F, Thomas AV, Lill C, Lenk T, Orlando LR, Kama J, Young AB, Landwehrmeyer GB, Trottier Y. A20 Interaction of huntingtin and the ryanodine receptor Journal of Neurology, Neurosurgery & Psychiatry. 81: A6.3-A7. DOI: 10.1136/jnnp.2010.222570.20 |
0.431 |
|
| 2009 |
Orlando LR, Ayala R, Kett LR, Curley AA, Duffner J, Bragg DC, Tsai LH, Dunah AW, Young AB. Phosphorylation of the homer-binding domain of group I metabotropic glutamate receptors by cyclin-dependent kinase 5. Journal of Neurochemistry. 110: 557-69. PMID 19457112 DOI: 10.1111/J.1471-4159.2009.06139.X |
0.559 |
|
| 2005 |
Kachroo A, Orlando LR, Grandy DK, Chen JF, Young AB, Schwarzschild MA. Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 10414-9. PMID 16280580 DOI: 10.1523/Jneurosci.3660-05.2005 |
0.568 |
|
| 2002 |
Orlando LR, Dunah AW, Standaert DG, Young AB. Tyrosine phosphorylation of the metabotropic glutamate receptor mGluR5 in striatal neurons. Neuropharmacology. 43: 161-73. PMID 12213270 DOI: 10.1016/S0028-3908(02)00113-2 |
0.629 |
|
| 2002 |
Dhavan R, Greer PL, Morabito MA, Orlando LR, Tsai L. The Cyclin-Dependent Kinase 5 Activators p35 and p39 Interact with the α-Subunit of Ca2+/Calmodulin-Dependent Protein Kinase II and α-Actinin-1 in a Calcium-Dependent Manner The Journal of Neuroscience. 22: 7879-7891. DOI: 10.1523/Jneurosci.22-18-07879.2002 |
0.353 |
|
| 2001 |
Orlando LR, Alsdorf SA, Penney JB, Young AB. The role of group I and group II metabotropic glutamate receptors in modulation of striatal NMDA and quinolinic acid toxicity. Experimental Neurology. 167: 196-204. PMID 11161608 DOI: 10.1006/exnr.2000.7542 |
0.624 |
|
| 2000 |
Sanchez RM, Wang C, Gardner G, Orlando L, Tauck DL, Rosenberg PA, Aizenman E, Jensen FE. Novel role for the NMDA receptor redox modulatory site in the pathophysiology of seizures. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 2409-17. PMID 10704515 DOI: 10.1523/Jneurosci.20-06-02409.2000 |
0.395 |
|
| 1997 |
Orlando LR, Luthi-Carter R, Standaert DG, Coyle JT, Penney JB, Young AB. N-acetylaspartylglutamate (NAAG) protects against rat striatal quinolinic acid lesions in vivo. Neuroscience Letters. 236: 91-4. PMID 9404819 DOI: 10.1016/S0304-3940(97)00769-6 |
0.621 |
|
| 1996 |
Orlando L, Standaert D, Penney J, Young A. Metabotropic glutamate receptors modulate striatal quinolinic acid toxicity Neuropharmacology. 35: A22. DOI: 10.1016/0028-3908(96)84732-0 |
0.635 |
|
| 1995 |
Orlando LR, Standaert DG, Penney JB, Young AB. Metabotropic receptors in excitotoxicity: (S)-4-carboxy-3-hydroxyphenylglycine ((S)-4C3HPG) protects against rat striatal quinolinic acid lesions. Neuroscience Letters. 202: 109-12. PMID 8787843 DOI: 10.1016/0304-3940(95)12219-2 |
0.636 |
|
| Show low-probability matches. |